Love it!
4K Studios is a division of NanoTech setup to
Love it!
4K Studios is a division of NanoTech setup to facilitate the conversion of traditional 35mm movie prints to 4K Ultra HD digital media. The division was setup and equipped with state of the art film scanners, and editing equipment. The goal of the studio is to provide the media division with content in the new 4K Ultra HD standard and use the services instead of paying minimum guarantees for content acquisition.
Go NTEK!
3
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...
Continue Reading
Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....
Continue Reading
What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...
Continue Reading
Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....
Continue Reading
Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...
Continue Reading
OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...
Continue Reading
Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...
Continue Reading
Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...
Continue Reading
A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...
Continue Reading
A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of the Merger and Collaboration Ikena Oncology, Inc. and Inmagene Biopharmaceuticals have announced an exciting merger agreement that aims to amplify their efforts in developing innovative treatment options for patients suffering from inflammatory diseases. The merger is designed to streamline the development of IMG-007, a cutting-edge therapeutic candidate...
Continue Reading
Tempest Therapeutics Advances Amezalpat in Pivotal Trial Tempest Therapeutics, Inc. (Nasdaq: TPST) is thrilled to announce a major step forward in the fight against hepatocellular carcinoma (HCC), having received approval from China’s National Medical Products Administration (NMPA) to initiate a pivotal trial. This trial aims to evaluate the efficacy of amezalpat...
Continue Reading
Chicago Atlantic BDC, Inc. Announces Dividend for the Upcoming Quarter In a notable development, Chicago Atlantic BDC, Inc. has declared a cash dividend of $0.34 per share for the upcoming quarter. This announcement is a significant milestone for shareholders, reflecting the company's solid financial foundation and commitment to returning value to its investors. This...
Continue Reading
Be Bio Secures $92 Million to Propel Clinical Innovations Be Biopharma, Inc. (NASDAQ: BIO), a front-runner in B Cell Medicines, has successfully closed a significant $92 million Series C financing round. This milestone will undoubtedly bolster their mission of advancing innovative therapies. The financing has drawn interest from a mix of new and existing investors,...
Continue Reading
Lifecore Biomedical to Report Second Quarter Financial Results Lifecore Biomedical, Inc. (NASDAQ: LFCR), a prominent contract development and manufacturing organization (CDMO), is gearing up to share its financial outcomes for the second quarter of fiscal year 2025. The report is scheduled for January 2, 2025, after the market closes. This presentation is highly...
Continue Reading